Study: Combined Therapies for Cardiac Arrest Give Better Neurological Outcomes

A new study in the July 17 issue of the Journal of the American Medical Association shows improved neurological results in in-hospital cardiac arrest patients requiring vasodepressors on whom a vasopressin-ephinepherine-steroid combination therapy is used.
 
The study included two years of data from 268 patients across three hospitals in Greece. Patients received epinephrine and either vasopressin or a placebo during CPR. Patients who received vasopressin had an 83.9 percent probability of returning to spontaneous circulation compared to the 65.9 percent probability of returning to spontaneous circulation of the other group. 
 
 
In addition, 13.1 percent of patients who received vasopressin were alive and had a favorable neurological recovery compared to just 5.1 percent of patients in the control group. 
 

More Articles on Quality: 

6 Steps to Lower Heart Failure Readmissions

Reducing Preventable Birth Injuries Through Evidence-Based Care, Enhanced Teamwork

Infographic: Communication Gaps From Outdated Technology Pose Threats, Costs

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars